Shares of Argent BioPharma Limited (LON:MXC – Get Free Report) rose 4.8% on Thursday . The company traded as high as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). Approximately 264 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 26,353 shares. The stock had previously closed at GBX 21 ($0.27).
Argent BioPharma Price Performance
The stock has a market capitalization of £9.65 million, a PE ratio of -13.25 and a beta of 1.03. The firm has a 50 day moving average price of GBX 21.44 and a 200-day moving average price of GBX 21.14.
About Argent BioPharma
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.
Featured Stories
- Five stocks we like better than Argent BioPharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Call Options Volume for These 2 Stocks Spiked Together
- What is a Stock Market Index and How Do You Use Them?
- MarketBeat Week in Review – 7/22 – 7/26
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20230125112218&h=45&w=95&zc=2){kind=logo}
